Patricia Pautier

Institut Gustave Roussy - - / France

Medical and Health Sciences / Medical Oncology

AD Scientific Index ID: 4475202

Gustave Roussy Institute

Registration, Add Profile,
Premium Membership

Print Your Certificate

Patricia Pautier's MOST POPULAR ARTICLES

1-) Olaparib plus bevacizumab as first-line maintenance in ovarian cancerI Ray-Coquard, P Pautier, S Pignata, D Pérol, A González-Martín, ...New England Journal of Medicine 381 (25), 2416-2428, 201918072019

2-) Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised …E Pujade-Lauraine, JA Ledermann, F Selle, V Gebski, RT Penson, ...The lancet oncology 18 (9), 1274-1284, 201717962017

3-) ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent diseaseN Colombo, C Sessa, A du Bois, J Ledermann, WG McCluggage, ...Annals of oncology 30 (5), 672-705, 201911762019

4-) Malignant effusions and immunogenic tumour-derived exosomesF Andre, NEC Schartz, M Movassagh, C Flament, P Pautier, P Morice, ...The Lancet 360 (9329), 295-305, 200211932002

5-) Cutaneous side-effects of kinase inhibitors and blocking antibodiesC Robert, JC Soria, A Spatz, A Le Cesne, D Malka, P Pautier, J Wechsler, ...The lancet oncology 6 (7), 491-500, 20056972005

ARTICLES

Add your articles